
Structural Heart Disease Device Developer
People's Finance News, February 7th: According to a message released by Chengdu, Chengdu Silara Medtech Inc. (referred to as "Silara Medtech") has officially signed an agreement to settle in Chengdu Tianfu International Bio City. It is reported that Silara Medtech plans to build its corporate headquarters, research and development center, and production base in the Bio City to systematically carry out the research, production, and sales of medical devices in the field of structural heart disease.